logo
Share SHARE
FONT-SIZE Plus   Neg

Protalix BioTherapeutics CEO David Aviezer To Retire - Quick Facts

Protalix BioTherapeutics Inc. (PLX) announced that David Aviezer has decided to retire after almost 12 years from his role as the Company's President and Chief Executive Officer. He will retire this year upon the completion of a process to nominate his successor.

In the meantime, Aviezer will continue serving as President and Chief Executive Officer and remains a member of the Board of Directors.

The company's Board will appoint a committee to select a new Chief Executive Officer.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toll Brothers, Inc. (TOL) reported second-quarter net income of $124.6 million, or $0.73 per share compared to $89.1 million, or $0.51 per share, a year ago. On average, 17 analysts polled by Thomson Reuters expected the company to report profit per share of $0.63, for the quarter. Analysts' estimates typically exclude special items. Pre-tax income was $199.2 million, compared to $140.4 million, prior year. Verizon and Ericsson are working together to test fifth generation or 5G wireless technology at the Indianapolis 500. Verizon said Monday that it has worked with Ericsson and Intel for 5G mobile fixed broadband service trials inside a house near the Indianapolis Motor Speedway. Facebook founder and CEO Mark Zuckerberg said he is not running for public office, amid rising speculation that his plans for traveling the U.S. indicated he is gearing up for a future presidential run.
comments powered by Disqus
Follow RTT